Sequent Scientific Ltd.
SEQUENT Share PricePharmaceuticals & Drugs
₹207.43
-5.2 (-2.4%)
As on December 4, 2025
Exchange Scrips: BSE512529NSESEQUENTISININE807F01027
Market Cap ₹ 5,242 Cr
P/E Ratio 328.73
Dividend Yield N/A
Performance
Market performance
Open210
High211.92
Volumes15,48,561
Prev207.43
Low206.05
As on2025-12-04
Historical performance
1 Year High257.85
3 Year High257.85
5 Year High336.5
1 Year Low117.35
3 Year Low61.8
5 Year Low61.8
Fundamentals
Company Valuation
Market Cap (₹Cr)
5,242
Face Value (₹)
2
P/E Ratio
328.73
Dividend Yield
N/A
Investment Returns
1 Year
1.9%
3 Years
119.2%
5 Years
29.6%
10 Years
N/A
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 216.21 | Bearish |
| 10-DMA | 220.94 | Bearish |
| 20-DMA | 227.12 | Bearish |
| 50-DMA | 214.31 | Bearish |
| 100-DMA | 197.25 | Bullish |
| 200-DMA | 180.55 | Bullish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 1 | 1 | 1 | 1 | 1 |
| Foreign Investors | 1 | 1 | 1 | 1 | 1 |
| Domestic Investors | --- | --- | --- | --- | --- |
| Public Investors | 144084 | 147319 | 158151 | 162573 | 154602 |
| Government | 1 | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 328.73.
- 3Y Stock Price CAGR of the stock is 29.1.
- The stock has a beta of 1.6.
- In the last financial year, the company had an EBITDA of ₹396 Million.
- The company generated revenue of ₹1783 Million in the previous financial year.
Sequent Scientific Ltd.
207.43-5.2 (-2.4%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1040114.3
No. of Shares: 5014 (Approx)
Performance:4%
P/L: ₹40114.3
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
